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Abstract  
Depression has been linked to failure in synaptic plasticity originating from 
environmental and/or genetic risk factors. The chronic mild stress (CMS) model 
regulates the expression of synaptic markers of neurotransmitter function and 
associated depressive-like behaviour. Moreover, mice heterozygous for the synaptic 
vesicle protein (SVP) vesicular glutamate transporter 1 (VGLUT1), have been 
proposed as a genetic model of deficient glutamate function linked to depressive-like 
behaviour. Here, we aimed to identify, in these two experimental models, mechanisms 
of failure in synaptic plasticity, common to stress and impaired glutamate function.  
First, we show that CMS induced a transient decrease of different plasticity markers 
(VGLUT1, synapsin 1, sinaptophysin, rab3A and activity regulated cytoskeletal protein 
Arc) but a long-lasting decrease of the brain derived neurotrophic factor (BDNF) as well 
as depressive-like behaviour. The immediate early gene (IEG) Arc was also 
downregulated in VGLUT1+/- heterozygous mice. In contrast, an opposite regulation of 
synapsin 1 was observed.  Finally, both models showed a marked increase of cortical 
Arc response to novelty.   
Increased Arc response to novelty could be suggested as a molecular mechanism 
underlying failure to adapt to environmental changes, common to chronic stress and 
altered glutamate function. Further studies should investigate whether these changes 
are associated to depressive-like behaviour both in animal models and in depressed 
patients.  
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 Introduction  
Increasing evidence suggests that depression is characterized by impaired brain 
plasticity that might originate from both environmental and genetic risk factors (Molteni, 
2009a).  In order to test this hypothesis, the regulation of different plasticity markers in 
experimental models based on stress paradigms or in genetic manipulations has been 
studied. For instance, the environmental chronic mild stress (CMS) model regulates the 
expression of synaptic proteins such as synaptic vesicle proteins (SVP), immediate 
early genes (IEG) and/or neurotrophins, critical for neuroplasticity as well as associated 
depressive-like behaviors. Specifically, CMS induces a downregulation of the SVP 
synapsin 1 (Silva et al., 2008; Bessa et al., 2009) and the brain-derived neurotrophic 
factor (BDNF) (Duman et al.,2006; Dang et al.,2009; Li et al.,2008), that might be 
linked to anhedonia and helplessness. Moreover, other models based on stress 
paradigms have shown decreased levels of synaptophysin together with other SVPs 
(Thome et al., 2001). However, these studies were carried out shortly after the 
termination of the stress procedure while CMS has shown to induce a long-lasting 
depressive-like behaviour (Elizalde et al., 2008). Thus, whether these synaptic proteins 
are involved in the long-term CMS induced behavioural alterations remains unknown.  
On the other hand, recent clinical (Uezato et al., 2009) and preclinical studies (Tordera 
et al., 2007; García-García et al., 2009) have linked decreased levels of the synaptic 
vesicle protein (SVP) vesicular glutamate transporter 1 (VGLUT1), with a key role in 
glutamate release in the forebrain (Fremeau et al., 2004; Wojcik et al., 2004), to 
depressive like behaviour. Specifically, decreased VGLUT1 levels in the frontal cortex 
of depressed subjects have been reported (Uezato et al., 2009) in postmortem studies. 
In addition, recent studies with the VGLUT1 heterozygous mice suggest that decreased 
VGLUT1 levels affects glutamate transmission (Balschun et al., 2009) and induces 
depressive-like behaviour comorbid with anxiety and impaired recognition memory 
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(Tordera et al., 2007). However, the regulation of other stress and/or glutamate 
sensitive plasticity markers has not been studied in these mice.  
Here, we aimed to identify in one environmental (chronic mild stress) and one genetic 
model (VGLUT1+/- mice) showing depressive-like behaviours, changes in the 
expression of genes critical for neuroplasticity, common to stress and impaired 
glutamate function. Firstly, we studied comparatively, how CMS and decreased 
VGLUT1 levels (VGLUT1 heterozygous mice), affects the expression of selected 
plasticity markers already suggested to be regulated by different forms of stress and/or 
glutamate function. Among them, the SVPs (VGLUT1, synapsin 1, sinaptophysin and 
rab3A), neurotrophins (BDNF) and the activity regulated cytoskeletal protein (Arc) were 
included. Moreover, in order to study the persistence of stress-induced changes, the 
expression of these plasticity markers was measured at short and long-term after the 
CMS procedure. Subsequently, some relevant mRNA changes detected by in situ 
hybridization were selected for protein expression studies by western-blot. Secondly, 
we aimed to study cortical and hippocampal Arc protein expression induced by 
exposure to a novel environment. Arc has been suggested to play a major role in brain 
areas displaying a prominent emotion-related synaptic plasticity (Ons et al., 2004; 
Vazdarjanova et al., 2002). Specifically, a striking Arc induction in telencephalic regions 
after exposure to novel environment, a mild emotional stressor that involves learning 
processes, has been reported (Ons et al., 2004; Vazdarjanova et al., 2002).  
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Methods and Materials 
 
Animals 
 
For the CMS procedure, male mice C57BL/6 mice (8-10 weeks of age) were housed in 
individual cages and allowed for 2 weeks to habituate before beginning 
experimentation. Food and water were available ad libitum for the duration of the 
experiments unless otherwise specified.  
Heterozygous VGLUT1 male mice (VGLUT1+/-; C57BL/6) (8-10 weeks of age) 
obtained from Dr S. Wojcik (Gottingen, Germany) were used. A colony of wild type 
(WT) and VGLUT1+/- mice were bred from heterozygous fathers and WT mothers 
(Harlan, France). Mice were weaned and genotyped at the age of 3 weeks.  
VGLUT1+/- mice were studied and compared to their WT littermates. Heterozygous 
mice exhibited no apparent phenotypic abnormalities during development and 
adulthood. 
All the animals were maintained in a temperature (21 ± 1 ºC) and humidity-controlled 
room (55 ± 2%) on a 12-h light-dark cycle (lights on 08.00 h) with food and water 
provided ad libitum unless otherwise specified. Experimental procedures and animal 
husbandry were conducted according to standard ethical guidelines of the European 
Communities Council Directive (2003/65/EC) Spanish legislation (Real decreto 
1201/2005) and approved by the Ethical Committee of University of Navarra.  
 
Experimental design 
Chronic mild stress. Mice were divided into control and CMS groups (n=64 
mice/group). Chronic mild stress (CMS) procedure was applied for six weeks (Elizalde 
et al., 2008). Anhedonic-like behavior was evaluated by weekly monitoring of sucrose 
intake in both control and CMS mice during the 6 weeks of the stress procedure and 
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one month after. One day (24 h) after the stress procedure a group of control (n=12) 
and CMS mice (n=12) were exposed to the forced swimming test. Similarly, one month 
after the stress procedure another group of control and CMS mice were tested in this 
paradigm. Mice exposed to this test were excluded from posterior neurochemical 
studies (Figure 1A). To study the short and long-term effects of CMS on the expression 
of different plasticity markers animals were killed by cervical dislocation 24 hours 
(short-term effects) or one month after CMS (long-term effects) (Figure 1B). For in situ 
hybridization studies (n=6 mice/group), after sacrifice, brains were rapidly removed and 
frozen in isopentane (-40 ºC) and for western blot (n=6 mice/group), the hippocampus 
and the frontal cortex was rapidly dissected and frozen in dry ice. In addition, short and 
long-term effects of CMS on cortical and hippocampal Arc expression induced by 
exposure to novel environment, was studied in a separate group of animals (n=6-8 
mice/group). Novel environment consisted on the placement of mice inside a cardboard 
box (15 × 28 × 20 cm) softly illuminated during 1 h before sacrifice (Figure 1B). 
Prefrontal cortex was rapidly dissected and frozen in dry ice. Moreover, as a control 
experiment, a separate group of control mice (n= 6, C57BL/6, 8-10 weeks of age) were 
placed in individual cages for two weeks and cortical and hippocampal Arc expression 
induced by exposure to novel environment was studied.  
VGLUT1+/- mice. Sucrose intake and forced swimming tests were applied to a group of 
VGLUT1+/- mice and WT littermates (n=12 mice/group), and these mice were excluded 
from posterior neurochemical studies. The expression of different plasticity markers in 
VGLUT1+/- and WT littermates was studied by in situ hybridisaton (n=6 mice/group) 
and western-blot studies (n=6 mice/group). In addition a separate group of animals 
(n=6-8 mice/group) were used to study Arc response to novelty.  
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Chronic mild stress procedure 
The following unpredictable mild stressors (2-3 in any 24 h period) were randomly 
applied for 6 weeks (Elizalde et al., 2008): stroboscopic illumination (8h), intermittent 
bell (10 db, 1s/10s) or white noise (4 h), rat odour (8h), cage tilt 45º (8 h), soiled 
bedding (6 h), paired housing (2h) overnight illumination, removal of nesting material 
(12 h) and confinement (1 h).  Once a week, during the 15 h of duration of the sucrose 
intake test (from 6 p.m to 9 a.m.) no stressors were applied.   
 
Sucrose intake test  
Anhedonic-like behaviour was evaluated by weekly monitoring of sucrose intake 
(Elizalde et al., 2008). Mice were first trained to drink a sucrose solution by exposing 
them to two standard drinking bottles, one containing 2.5 % sucrose and the other tap 
water, for every other night during one week. After this preliminary phase, mice were 
food deprived and exposed to the sucrose solution and water from 6:00 p.m. until 09:00 
h in the morning. The intake baseline for the sucrose solution was established, which 
corresponded to the average of three consecutive measurements.  
In the CMS procedure, mice were divided into two groups (CMS and non-stressed 
controls) matched for sucrose consumption and body weight. Mice were weekly given a 
15-h exposure to the sucrose solution and tap water as described above and during 
this test no stressors were applied.  In VGLUT 1+/- mice (n=12 mice/group), sucrose 
intake was evaluated in individualized mice during three consecutive weeks and the 
average of the sucrose intake of these three weeks was calculated.  The position of the 
2 bottles (right/left) was varied randomly from trial to trial. Body weight measurements 
were taken weekly and relative sucrose intake was calculated as absolute intake (g) 
per body weight.  
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Forced swimming test 
Mice were placed individually for 6 min into glass cylinders (height 24 cm, diameter 13 
cm) containing 14 cm of water, maintained at 22–23°C. The duration of immobility was 
recorded during the last 4 min of the 6 min testing period. A mouse was considered to 
be immobile when it floated in an upright position, and made only small movements to 
keep its head above water. Immobility times were scored by Ethovision XT 5.0 (Noldus, 
Netherland). 
 
In situ hybridization studies 
Coronal brain sections (14 µm thick) were serially cut with a cryostat. Slides were fixed 
in 4% paraformaldehyde in phosphate-buffered saline (PBS), acetylated with 0.25% 
acetic anhydride in 0.1 M triethanolamine buffer (pH 5.8). The oligonucleotides (Sigma 
Genosis, UK) complementary to the following mouse genes were used: 
VGLUT1: 5´CGGGGGCCTCGGAGGCTGCACTGTGCTGTGTGTGGCCCCGTAGGA3´ 
Synapsin 1: 5´-TGGCCTGAGAGGCAGACTGCTGAGGTGCTGCGGTGGGAC-3´  
Synaptophisin: 5´-TGGATCCAACCCAAACCTGCCCACTCCGGAACCCACCATG-3´ 
Rab3A: 5´-TCTTCTCACAGATCACGTCCACCAGACGTTCAAACGTC-3´ 
Arc: 5´-CTTGGTTGCCCATCCTCACCTGGCACCCAAGACTGGTATTGCTGA-3´ 
BDNF: 5´-GGTCTCGTAGAAATATTGCTTCAGTTGGCCTTTTGATACCGGGAC-3´ 
Oligonucleotides were 3´-tail labeled with [35S]dATP, specific activity >1,000 Ci/mmol 
(GE Healthcare Biosciences, Europe), using terminal deoxynucleotide transferase 
(Roche, Diagnostics, USA). Negative controls including sense oligonucleotides showed 
minimal background signals. Labeled probes were purified by chromatographyon 
Sephadex G-25 columns (Nick column, GEHealthcare Biosciences, Europe). The 
sections were incubated overnight in humid chambers (containing 50% formamide in 
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4x SSC) at 35-37 ºC, with 200 µl hybridization buffer (50% deionized formamide, 20% 
20xSSC, 10% dextran sulfate, 10% Denhardt’s solution; 500 lg/ml salmon sperm DNA; 
20 mM sodium phosphate; 100 mM DTT; 250 lg/ml yeast tRNA; and 1% N-
laurosylsarcosine) containing 1x106 cpm of the 35S-ATP labeled antisense. After 
incubation, slices were washed three times in SSC buffer at 55ºC for 20 min, followed 
by washing twice in SSC at room temperature for 60 min. Sections were then air-dried, 
and exposed to Biomax MR film (Kodak) for 5-7 days except for VGLUT1 (3 days). 
The relative abundance of mRNA in each region was determined by densitometric 
quantification of autoradiograms using an image analysis system (Scion Image, Scion 
Corporation, USA) correcting for nonspecific signals. Optical density values were 
calibrated to 35S tissue equivalents using 14C microscales (Amersham, UK) and the 
appropriate conversion factor. Densitometric values from three sections of each animal 
were averaged and expressed as nCi/g tissue. Percentage changes versus control or 
WT animals were calculated.  
 
Western-blotting studies 
Preparation of the protein extracts. Frontal cortex and hippocampus from CMS and 
control mice were rapidly dissected and homogenized in 50 mM Tris-HCl-sucrose 
buffer (pH 7.4, 4 ºC) and centrifuged at 900 g for 10 min. The resultant post-nuclear 
supernatant was centrifuged at 12800 g for 10 min and the pellet was suspended in 
Tris-HCl-sucrose buffer containing 0.32 M EDTA, 1 mM PMSF, 5 mg/ml aprotinine and 
5 mg/ml leupeptine to a final protein concentration of 0.8-1 mg/ml and stored at –80 
°
C.  
Western-blot. Protein extracts from only one individual were loaded in each lane of the 
blot.  Thus, in each blot protein extracts from 4-5 animals from two different groups 
(control and CMS or WT and VGLUT1+/-) were loaded. Equal amounts of protein (10-
50 μg) per lane were separated by SDS-PAGE (NuPage Bis-Tris 10%, InVitrogen) and 
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transferred onto a PVDF membrane (Hybond-ECL; Amersham Bioscience), in Tris 50 
mM, borate 50 mM buffer. The trans-blots were blocked for 1 h with 5 % not-fat milk in 
buffer PBS containing 0.1 % Tween 20 and then probed with VGLUT1 
(1:2.000;donated by Dr S. El Mestikawy, Paris, France and already tested in mice 
(Tordera et al., 2007)), Synapsin I (1:5000; Chemicon International) , Synaptophysin 
(1:5000; Chemicon International), Arc (1:1000; Santa Cruz Biotechnology)  and 
proBDNF (1:1000; Chemicon International) antibodies overnight at 4°C. Membranes 
were washed 3 times (PBS-Tween buffer, 10 min) and incubated for 2 h with respective 
secondary horseradish peroxidase-conjugated goat anti-rabbit for VGLUT1, synapsin 
1, proBDNF and Arc and goat anti-mouse antibodies for synaptophysisne (DAKO, U.K. 
1:10.000). Peroxidase activity was detected by chemiluminescence using SuperSignal 
West Pico (Pierce Biotechnology). Films were scanned and quantified using the 
ImageMaster 1D (Pharmacia Biotech, Sweden) software and normalised to β-actin.  
 
Statistical analysis 
Both behavioural and neurochemical studies were analyzed using Student t-test 
analysis with the exception of sucrose intake test for the CMS procedure in which  one 
way ANOVA repeated measures followed by Student t-test for individual weeks was 
applied. 
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Results 
 
Forced swimming and sucrose intake tests 
Mice body weight was not affected by CMS. Similarly, no differences in body weight 
were observed between VGLUT1+/- mice and WT littermates. CMS mice decreased 
sucrose intake (solution (g)/body weight) from the fourth week of CMS until the end of 
this procedure (Fig. 2A) (F1,118 = 3,14 p<0.05). In addition, a decrease in sucrose intake 
was also observed one month thereafter (Fig. 2B) (t(22)=2.13, p=0.04). VGLUT1+/- mice 
decreased also sucrose intake measured as the average of sucrose intake on three 
consecutive weeks (Fig. 2C) (t(22)=2.3, p=0.03). In addition, during the 15 h exposure to 
the test, water intake did not vary between the groups, and due to the small amount 
taken (around 0.3 ml) and the relatively big volume of sucrose solution intake (10-20 
ml), all the groups showed a preference for sucrose higher than 97%. Therefore, no 
major differences were detected in sucrose preference (sucrose intake/total intake) 
among the groups (data not shown). 
 
In the forced swimming test (FST), increased immobility times were observed in CMS 
exposed mice both short (Fig. 2D) (t(22)=2.5, p=0.02) and long-term after CMS (Fig.2E) 
(t(22)=2.24, p=0.03). On the other hand, VGLUT1+/- heterozygous mice showed a 
significant increase in the immobility time in the FST compared to their WT littermates 
(Fig. 2F) (t(22)=2.3, p=0.03). 
 
Regulation of synaptic vesicle proteins (SVPs) by chronic mild stress and 
decreased VGLUT1 levels 
 
CMS induced a short-term decrease of VGLUT1 mRNA levels in the frontal cortex 
(83.52 ± 5.8% vs control, t(10)=3.46, p=0.02) and in the CA1 region (71.24 ± 8.8% vs 
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control, t(10)=3.22, p=0.01) of the hippocampus (Fig. 3A). Similarly, 24 hours after the 
CMS, synapsin I mRNA was decreased in the cingulated cortex (83.23 ± 5.8% vs 
control, t(10)=2.33, p=0.04) and in the different hippocampal regions (84-88% vs control, 
t(10)=3.0, 5.0, 6.2, p=0.02, 0.001, 0.001 for CA1, CA3 and DG respectively) (Fig. 3B). In 
addition, a significant decrease in synaptophysin (t(8)=3.1, p=0.02) and Rab3A (t(8)=2.9, 
p=0.02) mRNA (Fig. 3C,D) levels in the cingulate cortex was observed. However, one 
month after the chronic stress procedure, a complete recovery of mRNA alterations 
induced by CMS over these SVPs was shown (Fig. 3 E-H).  
VGLUT1 heterozygous genotype was confirmed since a significant decrease in mRNA 
in cortical (~75% vs WT, t(10)=3.2, 2.8, p=0.01, 0.02 for frontal and cingulate cortex 
respectively) and hippocampal areas (~63-75% vs WT, t(10)=6.1, 4.9, 3.7 p=0.001, 
0.001, 0.004 for CA1, CA3 and DG respectively) (Fig. 4A) was shown. With regard to 
the rest of SVP, a significant increase (~140-145% vs WT) in synapsin I mRNA 
expression was found in the CA1 (t(10)=3.9, p=0.005), CA3 (t(10)=4.0, p=0.004)  and 
dentate gyrus (DG) (t(10)=4.0, p=0.003) regions of the hippocampus (Fig.4B). 
Synaptophysin mRNA levels were also increased, specifically in the CA1 region of the 
hippocampus (t(10)=3.4, p=0.01) (Fig. 4C). Finally, no changes were observed in Rab3A 
mRNA levels (Fig.4D).  Autoradiograms showing the expression of VGLUT1 and 
synapsin 1 mRNA in the dorsal hippocampus of both short-term CMS and VGLUT1+/- 
mice with their corresponding controls can be observed in Figures 5A and B 
respectively.  
 
Western studies on hippocampal protein extracts showed a significant decrease of 
VGLUT1 (79.5 ± 12.1% vs control, t(10)=2.5, p=0.04) and of synapsin 1 (67.29 ± 16.1% 
vs control, t(10)=2.8, p=0.02) in the group of mice exposed to CMS, when measured 24 
after the termination of the stress procedure (Fig 6A). In addition, a significant decrease 
of VGLUT1 in the frontal cortex (59.3 ± 5.2% vs WT, t(13)=3.49, p=0.004) and the 
hippocampus (54.7 ± 5.5% vs WT, t(13)=9.9, p=0.000) and an increase of synapsin 1 
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(129.69± 6.6% vs WT, t(10)=2.23, p=0.049) in VGLUT1+/- mice   could be observed (Fig 
6B). However, no changes in hippocampal synaptophysin protein levels were detected.  
 
Regulation of BDNF by chronic mild stress 
 
A persistent decrease in BDNF mRNA levels in the CA1 region of the hippocampus 
was shown both short and long-term after CMS (78.28 ± 8.8%) and 81.16± 4.5%), vs 
control respectively) (Fig. 7A,B,D). Western-blot analysis of the immature form of 
BDNF (proBDNF) protein levels in the hippocampus, revealed a significant decrease of 
this protein in CMS mice when measured (71.60 ± 11.2% vs control) one month after 
this procedure (Fig. 8B). However, no alterations on BDNF mRNA levels were found in 
VGLUT1 deficient mice (Fig. 7C).  
 
Regulation of Arc by chronic mild stress and decreased VGLUT1 levels  
 
A short-term decrease of Arc mRNA levels was observed in the frontal and cingulated 
cortex and in the CA1 region of the hippocampus of mice exposed to CMS (68-76% vs 
control, t(10)=2.6, 3.6, 2.8, p=0.03, 0.007, 0.03) (Fig.9 A,D). No changes in basal Arc 
mRNA were observed in any brain region of CMS mice in the long-term (Fig 9B).  
However, a positive correlation between Arc and VGLUT1 mRNA levels was detected 
in the frontal cortex of both short-term (r=0.82, p<0.05) and long-term CMS (r=0.84, 
p<0.05) mice.  
VGLUT 1 +/- mice showed a decrease in Arc mRNA levels in the frontal and cingulated 
cortex and in the CA1 region of the hippocampus (76-82% vs WT, t(10)=4.6,5.2,2.3, 
p=0.002, 0.001, 0.04 for frontal and cingulate cortex and CA1 respectively) (Fig 9 C,D).   
No changes in Arc protein expression in the frontal cortex or in the hippocampus of 
mice exposed to CMS (24 h) or in the VGLUT1+/- mice were detected (data not 
shown).  
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Arc protein expression was significantly increased in both the prefrontal cortex (151.8 ± 
13.3% vs control, t(10)=3.4, p=0.007) and in the hippocampus (140.2 ± 13.4% vs control, 
t(10)=2.3, p=0.049) of control mice when exposed to novel environment (Fig 10 A). 
Similarly, novelty induced Arc expression was higher in the prefrontal cortex of mice 
exposed to CMS when measured one day (142.9 ± 11.5% vs control, t(10)=2.85, 
p=0.02) (Fig. 10B) and one month (169.1± 22.1% vs control, t(10)=3.7, p=0.002) (Fig. 
10C) after the stress procedure as well as in VGLUT1 heterozygous mice (144.5 ± 
13.8% vs WT, t(10)=2.8, p=0.02) (Fig. 10D). However, in the hippocampus no significant 
differences between controls and CMS mice or WT and VGLUT1+/- mice were 
observed (Fig 10B-10D).  
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Discussion 
 
Here, we firstly show that in agreement with previous studies carried out in our 
laboratory (García-Gacía et al., 2009; Elizalde et al., 2008) both the genetic 
(VGLUT1+/- mice) and the environmental (chronic mild stress) model of depression 
showed helpless and anhedonic-like behavior. Unlike our previous studies, mice were 
free of a course of saline injections, which made the results more comparable to the 
neurochemistry studies carried out here. Subsequently, we aimed to identify 
mechanisms of failure in synaptic plasticity, common to stress and impaired glutamate 
function. We observed that CMS induced a transient decrease of different plasticity 
markers (VGLUT1, synapsin 1, sinaptophysin, rab3A and the activity regulated 
cytoskeletal protein; Arc) but a long-lasting decrease of the brain derived neurotrophic 
factor (BDNF). Among these, Arc mRNA expression was also downregulated in 
VGLUT1+/- heteozygous mice. In contrast, an opposite regulation of synapsin 1 was 
observed.  Moreover, both models showed a marked increase of cortical Arc response 
to novelty.   
 
Regulation of synaptic vesicle proteins by chronic mild stress and decreased 
VGLUT1 levels 
 
Synaptic vesicle proteins (SVPs) have been identified as possible factors involved in 
the pathophysiology of psychiatric disorders (Uezato et al., 2009; Eastwood and 
Harrison, 2001; Vawter et al., 2002). Importantly, alterations in the expression pattern 
of these proteins have shown to affect neural plasticity and connectivity as well as 
associated behaviour (Silva et al., 2008; Reinés et al., 2008; Tordera et al., 2007).  
Here, we studied the regulation of four SVPs (VGLUT1, synapsin 1, synaptophysin and 
Rab3A) critical for neurotransmitter release.  
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 The environmental chronic mild stress (CMS) model induced here a short-term 
decrease in the mRNA expression of the four SVPs in cortical regions, a specific 
downregulation of VGLUT1 in frontal cortex and CA1 and a downregulation of synapsin 
1 in all the hippocampal subfields. Moreover, both synapsin 1 and VGLUT1 proteins 
were decreased in the hippocampus. These changes, in brain areas specifically 
vulnerable to stress, have been suggested to contribute to the molecular effects of 
CMS on synaptic plasticity and connectivity (Thome et al., 2001; Silva et al., 2008; 
Bessa et al., 2009). In particular, an important role of synapsin 1 in synaptic 
remodelling of the cortex and hippocampus of stressed animals linked to depressive-
like behaviour has been suggested (Silva et al., 2008; Bessa et al., 2009). Moreover, 
other models based on stress paradigms have shown decreased levels of 
synaptophysin together with other SVPs (Thome et al., 2001). However, it is important 
to note that these studies and ours were carried out shortly after the termination of the 
stress procedure. In addition, we show here for the first time, no changes in any of the 
four SVP studied, either in cortical or hippocampal brain regions of CMS mice, when 
analyzed one month after the termination of the stress procedure. These novel results 
suggest that CMS triggers a transient decrease in the four SVPs that is not associated 
with either the development of anhedonic-like behaviour or with other long-lasting 
behavioral alterations described in our previous study (Elizalde et al., 2008). Yet they 
might still contribute to the initiation of acute depressive episodes. Importantly, distinct 
neurobiological mechanisms are suggested to be responsible for first depressive 
episodes, very often preceded by exposure to stressful life events, and subsequent, 
more autonomous, recurrences (Stroud et al., 2008). 
 
It should be noted however that previous observations in models based on early life 
stress (Aisa et al., 2009; Burton et al., 2007; Law et al., 2009) suggest that when 
adverse events are applied during brain development, the regulation of these SVPs are 
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long-lasting and therefore, negatively affect synaptic function and behavioral outcome 
later in life. The clinical relevance of these studies for depressive disorders specifically 
related to adverse events at developmental stages warrants further investigation.  On 
the other hand, several post-mortem studies suggest a key role for these proteins in 
more severe psychiatric disorders such as schizophrenia or bipolar disorders, which, 
are believed to be related to impaired synaptic plasticity and connectivity during 
developmental stages (Vawter et al., 2002; Eastwood et al., 2000; Honer et al., 1999; 
Uezato et al., 2009).    
 
The vesicular glutamate transporter 1 (VGLUT1) is the major isoform in cortical and 
hippocampal regions (Takamori et al., 2000; Fremeau et al., 2001), where it plays a 
key role in the vesicular uptake and synaptic transmission of glutamate (Wojcik et al., 
2004: Fremeau et al., 2004). The functional significance of decreased VGLUT1 levels 
in the VGLUT1+/- mice for the synaptic transmission has been recently investigated. A 
recent study, using a different strain of VGLUT1 heterozygous mice, shows impaired 
hippocampal long-term potentiation suggesting reduced glutamate release under high 
frequency stimulation (Balschun et al., 2009). In agreement with this, we recently 
showed in these mice decreased cortical and hippocampal levels of the excitatory 
aminoacid transpoter 1 (EAAT1) (García-García et al., 2009), a glial transporter that 
can be regulated by the amount of glutamate released into the synaptic cleft (Duan et 
al., 1999; Liang et al., 2008). Thus, the anhedonic and helpless behaviour shown by 
these mice could be linked to decreased glutamate transmission in those areas in 
which VGLUT1 is the major isoform.  In keeping with this, recent post mortem studies 
showing decreased cortical VGLUT1 in depressed subjects (Uezato et al., 2009) 
together with clinical findings of an excitatory inhibitory imbalance in the cortex of 
depressed patients (Sanacora et al., 2004; Bhagwagar et al., 2007) suggest that 
decreased VGLUT1 levels has functional and clinical implications. Yet, other 
postmortem studies suggest that variations in VGLUT1 in different cortical areas could 
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be also involved in bipolar disorder or schizophrenia (Oni-Orisan et al., 2008; Uezato et 
al., 2009; Eastwood and Harrison 2010).  
 
Decreased VGLUT1 levels affected also the expression of other SVPs. A striking 
upregulation of both mRNA and protein hippocampal levels of synapsin 1 were shown 
in VGLUT1+/- mice. It is noteworthy that VGLUT1 colocalizes fully with synapsin 1 in 
the hippocampus (Bogen et al., 2009) and that development of glutamatergic synaptic 
vesicles and synapses appears to be synapsin 1 dependent (Bogen et al., 2009; 
Fremeau et al., 2004; Wojcik et al., 2004). We suggest that, synapsin 1 upregulation 
could respond to a need of maintaining the vesicle pool integrity in the reserve pool 
(Bogen et al., 2006), in where, it preferentially localizes and has a specific role 
tethering synaptic vesicles to each other and maintaining them in the vicinity of the 
active zone (Fdez et al., 2006). In line with this, only a small reduction (~15 %) in the 
reserve pool of synaptic vesicles of hippocampal excitatory terminals was shown in 
VGLUT1+/- mice (Tordera et al., 2007) compared to the around 50% reduction in both 
synaptic vesicles and synapsin 1 found in the VGLUT1 knockouts (Fremeau et al., 
2004). Yet, further studies would be needed to explore the molecular mechanism 
underlying synapsin 1 upregulation in these mice. Finally, despite the upregulation of 
synaptophysin mRNA in CA1 of VGLUT1+/- mice, that could be linked to synapsin 1 
(Lietz et al., 2003), protein levels of this integral membrane SVP were not changed. 
These results suggest that genetic ablation of one allele of VGLUT1 might induce 
compensatory mechanisms that alter the vesicle protein composition.  
  
Taken together, our results show dissociation between synapsin 1 expression levels 
and depressive-like behaviours. Firstly, development of long-lasting anhedonia or 
helplessness (Elizalde et al., 2008) can occur despite a full recovery of synapsin 1 
expression levels after CMS. Secondly, synapsin 1 is regulated in an opposite direction 
in short-term CMS and VGLUT1+/- mice while, both models show anhedonia and 
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helpless behaviour.  Yet, dissociations reported here do not fully exclude the possibility 
of a direct involvement of SVPs in depressive like behaviour. Further studies should 
investigate the regulation of these proteins in other brain regions as well as possible 
changes in their functional synaptic/neuronal  properties.   
 
On the other hand, our results suggest that decreased VGLUT1 in both short-term 
CMS and VGLUT1+/- mice could lead to an altered glutamate function that could be 
associated to depressive-like behavior.   
 
Increased cortical Arc response to novel environment in both models 
 
Arc (activity regulated cytoskeletal protein) is an effector immediate early gene rapidly 
activated by synaptic activity (Guzowski et al., 2006; Tzingounis and Nicoll, 2006) that 
might bridge neuronal activity with structural and functional changes (Lyford et al., 
1995). Importantly, a causative role for Arc in memory formation is quite established 
(Bramham et al., 2008) and a possible role in both synaptogenesis (Ujike et al., 2002) 
and neurogenesis (Bramham et al., 2008; Larsen et al., 2007) has been also 
suggested. Hypothesis linking depression to impaired synaptic plasticity and 
connectivity in the forebrain suggests that Arc, together with other activity regulated 
synaptic proteins, could form part of the altered synaptic “molecular context” of this 
illness. Yet, no evidence causally linking Arc to any aspect of depression has been 
established.  
  
Constitutive Arc mRNA expression was downregulated in cortical and hippocampal 
areas (CA1) by both stress and decreased VGLUT1 levels. Given that Arc expression 
is highly regulated by glutamate synaptic release (Steward et al.,2001; Bramham et al., 
2009) these findings would agree with the idea of deficient glutamate transmission in 
both short-term CMS and VGLUT1+/- models, in those areas mainly VGLUT1 
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dependent. Moreover, a positive correlation between Arc and VGLUT1 mRNA cortical 
levels was found in CMS mice. However, western studies showed no changes in Arc 
protein expression suggesting that the functional relevance of mRNA alterations might 
be limited.    
 
Most importantly, we found an increased cortical expression of Arc after exposure to 
novel environment in CMS and VGLUT1+/- mice. Previous studies have shown that 
novel experience activates a cell-specific genomic program in which Arc function 
seems to play an important role (Pinaud et al., 2001; Vazdarjanova et al., 2002). Novel 
environment is considered an emotional “processing” stressor in that it requires 
cognitive processing but does not represent an immediate physical threat (Herman et 
al., 1997). Importantly, the medial prefrontal cortex (mPFC) is a key component of the 
neuronal circuitry mediating responses to novelty including those directed to emotional 
control and memory formation (Roozendaal, 2002). Thus, altered inducible Arc levels in 
the prefrontal cortex of both models, could be reflecting either poor behavioral control 
of stress or a compensation for a deficient working memory. Indeed, both models have 
previously shown impaired recognition memory (Tordera et al., 2007; Elizalde et al., 
2008), which, is highly dependent of the prefrontal cortex. Interestingly, increased 
cortical Arc response to mild stress has been also observed in other genetic models of 
depression (Molteni et al., 2009). Moreover, matching with these experimental studies, 
various clinical studies have shown cortical hyperactivity in depressed patients 
following exposure to different processing tasks (Wagner et al., 2006; Siegle et al., 
2006; Konarski et al., 2009; Brody et al., 2001; Yoshimura et al., 2009). Thus, this IEG 
could form part of the “dysfunctional synaptic molecular context” of major depression 
and perhaps, underlie either behavioural disinhibitions or an altered cognitive function 
such as attention to environmental events in depressed patients. 
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Yet, the molecular consequences of an increased Arc expression after exposure to 
novel environment should be further explored. For instance, it could be studied whether 
increased expression of Arc induces an increase in AMPA remodelling in the synapsis, 
which might affect to the synaptic strength (Braham et al., 2008).   
 
Long lasting decreased BDNF after CMS 
 
Brain derived neurotrophic factor (BDNF) was affected by stress but not by decreased 
VGLUT1 levels. BDNF is a neurotrophin with a key role on synaptic transmission in 
addition to the stimulation of growth, differentiation and survival of neurones. The 
neurotrophin hypothesis of depression is based largely on observations that decreases 
in hippocampal BDNF levels are correlated with stress-induced depressive behaviours 
and that antidepressant treatment enhances the expression of BDNF (Duman and 
Monteggia 2006).  Further low levels of brain and serum  BDNF is suggested to be 
associated with major depression (Sen et al., 2008; Nestler, 2002;  Altar et al., 2009).  
 
The long-lasting helpless and anhedonic like behaviour induced by CMS could be 
associated to the long-lasting decrease in BDNF mRNA as well as proBDNF protein 
that we found in the hippocampus. Further, long-lasting downregulations of 
hippocampal BDNF have been found in previous mice studies, using the chronic social 
defeat stress (Tsankova et al., 2006) and CMS (Song et al., 2006).  Thus, unlike the 
SVPs studied here, decreased hippocampal BDNF seems to form part of the long-
lasting molecular effects of stress. Moreover, it could address together with the 
increased cortical Arc response to novelty, molecular mechanism involved in major 
depression disorders triggered by exposure to stressful life events in adult life, even, on 
a longitudinal perspective. 
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Conclusions 
 
Among the different synaptic plasticity markers studied here, increased cortical Arc 
response to novelty could be a marker of increased neuronal activity, common to 
chronic mild stress and an altered glutamate function as well as associated depressive-
like behaviour. Moreover, it could be suggested as a molecular mechanism underlying 
failure to adapt to environmental changes both in animal models and in depressed 
patients.  
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 Figure legends 
Figure1. Time course of the CMS procedure. (A) Short and long-term effects of CMS 
on sucrose intake and forced swimming test. (B) Short and long-term effects of CMS 
on the expression of synaptic plasticity proteins (neurochemistry) and on induced 
cortical Arc protein expression after novelty exposure. Abbreviations: CMS, chronic 
mild stress; FS, forced swimming test.  
 
Figure 2. Performance of CMS and control mice in the sucrose intake and in the forced 
swimming test both at short (A,D) and long-term (B,E). In addition, performance of 
VGLUT1 heterozygous and wild type (WT) mice on the sucrose intake test (C) and on 
the forced swimming test (F). Values show the mean±SEM (n=12 mice/group for FST 
and test carried out in the VGLUT1+/- model, n=60 mice/group for sucrose intake test 
during the CMS procedure and n=48 mice/group for the sucrose intake one month 
after). *p<0.05 vs corresponding control or WT mice (One-way ANOVA repeated 
measures for the sucrose intake test during CMS, and Student t-test for the rest of the 
experiments).  
 
Figure 3. Short and long-term effects of chronic mild stress (CMS) on VGLUT1 (A, E), 
synapsin 1 (B, F), synaptophysin (C, G) and Rab3A (D, H) mRNA in different forebrain 
regions. Each column represents mean ± SEM (n= 6 mice/group). **p< 0.01, *p <0.05 
versus controls (Student t-test). Abbreviations: Fr, frontal cortex: Cg, cingulated cortex.  
 
Figure 4. Expression of VGLUT1 (A), synapsin 1 (B), synaptophysin (C) and Rab3A 
(D) mRNA in different forebrain regions of VGLUT1+/- mice compared to WT 
littermates. Values show the mean ± SEM (n= 6 mice/group). **p< 0.01; *p <0.05 
 34 
versus WT mice (Student t-test). Abbreviations: WT, Wild Type; Fr, frontal cortex; Cg, 
cingulated cortex; DG, dentate gyrus. 
 
 
Figure 5. Representative autoradiograms showing the regulation of hippocampal 
VGLUT1 and synapsin 1 mRNA levels by short-term CMS (A) and by VGLUT1+/- mice 
(B).   
 
Figure 6. Protein expression of hippocampal synapsin 1 (Syn1) and of VGLUT1 (Syp) 
in the hippocampus and frontal cortex of short-term CMS (A) and VGLUT1+/- (B) mice. 
Values show the mean ± SEM (n= 6 mice per group). ** p< 0.01, *p<0.05, versus 
corresponding control or WT mice respectively (Student t-test).  
 
Figure 7. Effect of chronic mild stress, at short (A) and long-term (B) and of decreased 
VGLUT1 levels (VGLUT1+/- mice) (C) on BDNF mRNA in different forebrain regions. In 
(D), representative autoradiogram showing the decreased of BDNF mRNA expression 
in CA1 by long-term CMS. Values show the mean ± SEM (n= 5/6 mice/group). * P 
<0.05 versus WT mice (Student t-test).  
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Figure 8. Short (B) and long-term (B) effects of CMS on proBDNF protein levels in the 
hippocampus. Values show the mean ± SEM (n= 6 mice per group). *p<0.05 versus 
corresponding control mice (Student t-test). 
 
Figure 9. Effect of chronic mild stress (CMS), at short (A) and long-term (B) and of 
decreased VGLUT1 levels (VGLUT1+/- mice) (C) on Arc mRNA expression in different 
forebrain regions. In (D) representative autoradiograms showing decreased Arc mRNA 
in the frontal cortex of VGLUT1+/- and short-term CMS mice. Values show the mean ± 
SEM (n= 5/6 mice/group). **p< 0.01, *p <0.05 versus WT mice (Student t-test). 
 
Figure 10. Effect of exposure to novel environment on cortical and hippocampal Arc 
expression in control mice (A). In B-D, effect of exposure to novel environment on 
cortical and hippocampal Arc expression in mice exposed to CMS, at short (B) and 
long-term (C) compared to control mice and in VGLUT1+/- mice (D) compared to WT. 
Values show the mean ± SEM (n= 6 mice per group). **p<0.01, *p<0.05, versus 
corresponding WT or control mice respectively (Student t-test). 
 
 
 
 
. 
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